Entheon Biomedical Corp. (CSE:ENBI.X)
0.0600
0.00 (0.00%)
At close: Sep 2, 2026
Entheon Biomedical Balance Sheet
Financials in millions CAD. Fiscal year is December - November.
Millions CAD. Fiscal year is Dec - Nov.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Cash & Equivalents | 0.32 | 0.32 | 0.14 | 0.34 | 0.68 | 2.05 |
Cash & Short-Term Investments | 0.32 | 0.32 | 0.14 | 0.34 | 0.68 | 2.05 |
Cash Growth | -20.78% | 135.79% | -60.39% | -49.33% | -66.81% | -27.77% |
Other Receivables | 0.18 | 0.01 | 0 | 0.01 | 0.04 | 0.03 |
Receivables | 0.18 | 0.01 | 0 | 0.01 | 0.04 | 0.03 |
Inventory | - | - | - | - | - | 0.03 |
Prepaid Expenses | 0.01 | 0.02 | 0.04 | 0.05 | 0.02 | 1.1 |
Total Current Assets | 0.52 | 0.35 | 0.18 | 0.4 | 0.74 | 3.21 |
Property, Plant & Equipment | - | - | - | - | - | 0.16 |
Long-Term Investments | - | - | - | - | - | 0.7 |
Other Intangible Assets | - | - | - | - | - | 5.9 |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | - |
Total Assets | 0.52 | 0.35 | 0.19 | 0.4 | 0.77 | 9.98 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Accounts Payable | 0.04 | 0.03 | 0.04 | 0.08 | 0.14 | 0.93 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0.02 | - |
Total Current Liabilities | 0.04 | 0.03 | 0.04 | 0.09 | 0.15 | 0.93 |
Total Liabilities | 0.04 | 0.03 | 0.04 | 0.09 | 0.15 | 0.93 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Common Stock | 20.61 | 20.61 | 20.11 | 19.96 | 19.35 | 19.35 |
Retained Earnings | -20.15 | -20.88 | -20.92 | -21.31 | -21.61 | -13.55 |
Comprehensive Income & Other | 0.02 | 0.59 | 0.96 | 1.66 | 2.87 | 3.24 |
Shareholders' Equity | 0.48 | 0.32 | 0.15 | 0.32 | 0.61 | 9.05 |
Total Liabilities & Equity | 0.52 | 0.35 | 0.19 | 0.4 | 0.77 | 9.98 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
Net Cash (Debt) | 0.32 | 0.32 | 0.14 | 0.34 | 0.68 | 2.05 |
Net Cash Growth | -20.78% | 135.79% | -60.39% | -49.33% | -66.81% | -27.77% |
Net Cash Per Share | 0.02 | 0.02 | 0.02 | 0.06 | 0.12 | 0.38 |
Filing Date Shares Outstanding | 13.86 | 13.86 | 8.86 | 5.91 | 5.91 | 5.91 |
Total Common Shares Outstanding | 13.86 | 13.86 | 8.86 | 5.91 | 5.91 | 5.91 |
Working Capital | 0.47 | 0.32 | 0.14 | 0.31 | 0.59 | 2.28 |
Book Value Per Share | 0.03 | 0.02 | 0.02 | 0.05 | 0.10 | 1.53 |
Tangible Book Value | 0.48 | 0.32 | 0.15 | 0.32 | 0.61 | 3.15 |
Tangible Book Value Per Share | 0.03 | 0.02 | 0.02 | 0.05 | 0.10 | 0.53 |
Machinery | - | - | - | - | - | 0.16 |
Leasehold Improvements | - | - | - | - | - | 0.04 |